The study found that the tRNA methyltransferase NSUN2 in HNSCC was significantly upregulated and increased the risk of death in HNSCC patients, indicating that NSUN2 is a potential therapeutic target and prognostic marker in HNSCC125. The gene discussed is NSUN2; the disease is head and neck squamous cell carcinoma.